MEET MEDICAL SCIENTIST AND RESEARCHER AISLING O'BRIEN
We want to show you a glimpse of the work that our researchers do in a hospital immunology lab to help Make More Survivors.
In this video, Aisling O’Brien, a Medical Scientist funded by your generosity, tells us more about her research into diseases that affect the immune system, like Multiple Myeloma.
If you are interested in learning more about Aisling’s work, and the work of our other researchers, you can read more on our current research projects and our research strategyhere.
Medical Scientist Aisling O’Brien, who is funded by your generosity, tells us more about her work in a hospital immunology lab.
WORLD GYNAECOLOGICAL ONCOLOGY DAY AND A NEW PODCAST
September 20th was World Gynaecological Oncology Day - World GO Day – a day where patients and advocates around the world unite to raise awareness about all five gynaecological cancers (cervical, ovarian, uterine, vaginal and vulval cancers) and their risk factors.
As part of this awareness it’s been an honour to work with the Irish Society of Gynaecological Oncology on the ISGO Podcast series hosted by Dr. Doireann O’Leary. This podcast series combines people’s personal experience with gynaecological cancers with the latest evidence-based information from experts in their field.
InEpisode 1- The Lived Experience of Genetic Testing - Krista tells her story of having preventative surgery after learning she had a BRCA gene mutation. Kat tells us about her experience of Ovarian and Endometrial (Uterine) cancers and Lynch Syndrome. This episode is livenow.
Episode 2 (out on October 4th) - Ovarian Cancer and PARP Inhibitors -Dr. Dearbhaile Collins, Consultant Medical Oncologist explains medications called PARP Inhibitors, a recent breakthrough in ovarian cancer treatment and Jenny tells us of her experience of living with ovarian cancer and taking a PARP Inhibitor.
Episode 3 (out on October 11th) - Redefining Palliative Care - Dr. Karie Dennehy and Dr. Miriam Colleran, Consultants in Palliative Medicine help us to understand their role and how they support patients and families. Anne shares her own experience of palliative care and ovarian cancer.
Symptoms of gynaecological cancer vary depending on the type of cancer. If you are experiencing any of the symptoms below for 2 weeks or more please speak to your G.P.
COME THROUGH THE LAB DOORS
Would you like to meet some of the scientists you so kindly support and have a look inside some of the laboratories where they do their work?
Join us for a free Cancer Research Showcase in the Trinity Translational Medicine Institute which is on the grounds of St. James’s Hospital in Dublin 8.
The showcase and tour is from 6pm-8pm on Thursday, October 19th and there will be tea and coffee served beforehand.
Sunday, September 24th, was World Cancer Research Day - it's a day where people across the globe come together to promote cancer research in order to reduce the number of people who develop cancer, improve survival rates and the quality of life for people who have received a cancer diagnosis.
To mark this extraordinary day our amazing volunteers were on the streets around Ireland collecting generous donations to help us fund the essential cancer research we are funding all around the country. We are delighted to share that almost €50,000 has been raised!!!!
Thank you to each and everyone who turned out to support from schools, local community groups, Breakthrough-funded researchers, corporate partners, families and friends. Thank you to everyone who donated so generously and also shared their own cancer stories with us. As always, we are sincerely grateful for all of your amazing support.
We still have a few collections going on over the coming weeks so if you spot us pop by to say hello!
You are receiving this email because you are a Breakthrough Cancer Research supporter or subscriber. We wish to keep you updated on the amazing research and cancer trials that your generous donations are funding. Please note that you can unsubscribe at any time. Thank you as always for your support.
